Catalent, Inc. (NYSE: CTLT) announced that it has completed the expansion of its clinical supply facility in Schorndorf, Germany. The Schorndorf site, Catalent's flagship European facility, provides comprehensive clinical supply services, including packaging, storage and distribution. The latest expansion of the clinical supply facility is expected to solidify Catalent's foothold in the growing clinical trials space and expand its Clinical Development & Supply network worldwide. Significance of the Latest Expansion The expansion increases the site's footprint, thereby adding storage and handling of clinical trial supply materials at controlled room temperatures. It also creates space in the original building to accommodate the installation of a new, fully automatic bottle-filling line, along with a dedicated area for Catalent's FastChain demand-led supply service. These added capabilities are expected to support a continued high level of service to Catalent's pharma and biotech customers and the patients they serve. The company's FastChain service is a continuous Good Manufacturing Practices approach that decouples primary from secondary packaging to enable timely and cost-effective adaptation and regional supply of clinical materials on demand. Per management, the Schorndorf site is crucial for the company's ability to meet customer demand for clinical packaging solutions, ...